Ferronova

Medical Devices & EquipmentSeries AAustraliaferronova.com.au

Latest round

Series A

Last raised

Jan 2023

Total raised

$7.9M

Investors

19

About Ferronova

Ferronova Pty Ltd is dedicated to advancing surgical oncology through its development of specialized tracer systems.000 mn coming from a grant provided by the Government of South Australia in January 2023.Ferronova specializes in innovative surgical oncology tracer systems designed to enhance the treatment guidance and staging of complex cancers, particularly upper gastrointestinal cancers such as gastric and esophageal cancers. The flagship product, FerroTrace®, is a mannose-labelled iron-oxide nanoparticle that facilitates the accurate detection of high-risk lymph nodes and early identification of metastatic spread. By improving the mapping of the lymphatic network, FerroTrace® aids surgeons in making informed clinical decisions during procedures, ultimately aiming to increase patient survival rates. This technology can be utilized before, during, and after surgery and is designed to work in conjunction with infrared dyes for enhanced intra-operative visualization.Ferronova operates on a business model that emphasizes partnerships with medical institutions and clinical settings, resulting in a direct-to-consumer structure where products like FerroTrace® are utilized in surgical procedures. Revenue is generated through the sale of FerroTrace® and potentially other future products under development, primarily through contracts with hospitals and surgical centers engaged in oncology treatments. The transactions typically involve bulk orders for the nanoparticles, which are supplied to healthcare providers for use in surgeries aimed at improving cancer treatment outcomes.000 mn to accelerate product commercialization and expand its market presence. The company is looking to introduce new products addressing unmet needs in surgical oncology and plans for geographic expansion into markets with high cancer prevalence, particularly in North America and Europe, by 2024. In December 2025, Ferronova Pty Ltd.

Who invested in Ferronova

19 investors across 2 rounds

See all investors in Ferronova

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jan 9, 2023

    Amount

    $5.5M

    Investors

    Locked

  2. Series A

    May 15, 2020

    Amount

    $2.4M

    Investors

    Locked

Questions about Ferronova

Who invested in Ferronova?

Ferronova has 19 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Ferronova raised?

Ferronova has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Ferronova last raise money?

Ferronova's most recent round on record is a Series A, in Jan 2023.

What does Ferronova do?

Ferronova Pty Ltd is dedicated to advancing surgical oncology through its development of specialized tracer systems.

Where is Ferronova headquartered?

Ferronova is headquartered in Australia.

Which VCs invest in companies like Ferronova?

Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back medical devices & equipment companies at Ferronova's stage. Their profiles are linked below.

Raising like Ferronova? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.